학술논문
Phanes Therapeutics receives FDA Fast Track designation for PT886
Document Type
News
Author
Source
M2 Pharma. March 21, 2024
Subject
Language
English
Abstract
M2 PHARMA-March 21, 2024-Phanes Therapeutics receives FDA Fast Track designation for PT886 (C)2024 M2 COMMUNICATIONS Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company, announced on Wednesday that it has [...]